These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15459089)

  • 21. Association of paraoxonase 1 (PON1) gene polymorphisms and concentration with essential hypertension.
    Turgut Cosan D; Colak E; Saydam F; Yazıcı HU; Degirmenci I; Birdane A; Colak E; Gunes HV
    Clin Exp Hypertens; 2016; 38(7):602-607. PubMed ID: 27668323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress.
    Moren X; Deakin S; Liu ML; Taskinen MR; James RW
    J Lipid Res; 2008 Jun; 49(6):1246-53. PubMed ID: 18314464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between PON1 enzyme activities in human ovarian follicular fluid and serum specimens.
    Kim K; Bloom MS; Fujimoto VY; Browne RW
    PLoS One; 2017; 12(2):e0172193. PubMed ID: 28196109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation.
    Hine D; Mackness B; Mackness M
    IUBMB Life; 2012 Feb; 64(2):157-61. PubMed ID: 22184096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosoma congolense: paraoxonase 1 prolongs survival of infected mice.
    Bhasin KK; Yu JM; Tward A; Shih D; Campbell DA; Lusis AJ
    Exp Parasitol; 2006 Nov; 114(3):240-5. PubMed ID: 16682028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
    Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
    Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux.
    Gaidukov L; Rosenblat M; Aviram M; Tawfik DS
    J Lipid Res; 2006 Nov; 47(11):2492-502. PubMed ID: 16914770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of HDL mimetic peptide 4F on PON1.
    Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M
    Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status.
    Rozek LS; Hatsukami TS; Richter RJ; Ranchalis J; Nakayama K; McKinstry LA; Gortner DA; Boyko E; Schellenberg GD; Furlong CE; Jarvik GP
    J Lipid Res; 2005 Sep; 46(9):1888-95. PubMed ID: 15995178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraoxonase 1 and HDL maturation.
    Gugliucci A; Menini T
    Clin Chim Acta; 2015 Jan; 439():5-13. PubMed ID: 25261854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
    Zhang B; Fan P; Shimoji E; Xu H; Takeuchi K; Bian C; Saku K
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.
    de Souza JA; Menin A; Lima LO; Smiderle L; Hutz MH; Van Der Sand CR; Van Der Sand LC; Ferreira ME; Pires RC; Almeida S; Fiegenbaum M
    Clin Biochem; 2015 Nov; 48(16-17):1039-44. PubMed ID: 26079344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism.
    Schiavon R; Battaglia P; De Fanti E; Fasolin A; Biasioli S; Targa L; Guidi G
    Clin Chim Acta; 2002 Oct; 324(1-2):39-44. PubMed ID: 12204423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
    Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
    J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
    Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
    J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Shen Y; Ding FH; Sun JT; Pu LJ; Zhang RY; Zhang Q; Chen QJ; Shen WF; Lu L
    Cardiovasc Diabetol; 2015 May; 14():52. PubMed ID: 25964115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II.
    Hannuksela ML; Brousseau ME; Meyn SM; Nazih H; Bader G; Shamburek RD; Alaupovic P; Brewer HB
    Atherosclerosis; 2002 Dec; 165(2):205-20. PubMed ID: 12417271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.
    Zhang B; Eto S; Fan P; Bian C; Shimoji E; Saito T; Saku K
    Clin Nephrol; 2003 Oct; 60(4):257-65. PubMed ID: 14579940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.